Floatz logo

Bicarbonate Ion

Myofascial Pain Syndrome

Cairo UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Myofascial Pain Syndrome cohort.

Asset / SponsorPhaseRating
Granisetron
Karolinska Institutet
Phase 4BB
Imc-1
Innovative Med Concepts, LLC
Phase 2B
Capsaicin
Stamford Hospital
Phase 2CCC
Solvazinc
Cairo University
Early Phase 1C
Prilocaine
Bursa City Hospital
N/AD

View all 11 →

Same molecule, other indications

Bicarbonate Ion is also rated in:

obesity disorderActive
CC
Indicative · Phase 1
46 / 100
View asset →
prostate cancerActive
CC
Indicative · Phase 1/2
44 / 100
View asset →
metabolic acidosisDormant
CC
Indicative · Phase 1
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →